BR9708161A - Peptídeos com aumentada afinidade de ligação para moléculas hla - Google Patents
Peptídeos com aumentada afinidade de ligação para moléculas hlaInfo
- Publication number
- BR9708161A BR9708161A BR9708161A BR9708161A BR9708161A BR 9708161 A BR9708161 A BR 9708161A BR 9708161 A BR9708161 A BR 9708161A BR 9708161 A BR9708161 A BR 9708161A BR 9708161 A BR9708161 A BR 9708161A
- Authority
- BR
- Brazil
- Prior art keywords
- peptides
- binding affinity
- increased binding
- hla molecules
- hla
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 108010086377 HLA-A3 Antigen Proteins 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1311396P | 1996-03-11 | 1996-03-11 | |
PCT/US1997/003778 WO1997033602A1 (en) | 1996-03-11 | 1997-03-10 | Peptides with increased binding affinity for hla molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9708161A true BR9708161A (pt) | 1999-07-27 |
Family
ID=21758378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9708161A BR9708161A (pt) | 1996-03-11 | 1997-03-10 | Peptídeos com aumentada afinidade de ligação para moléculas hla |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0914142B9 (pt) |
JP (2) | JP2001504799A (pt) |
CN (1) | CN1225590A (pt) |
AT (1) | ATE511849T1 (pt) |
AU (1) | AU2203797A (pt) |
BR (1) | BR9708161A (pt) |
CA (1) | CA2248657A1 (pt) |
ES (1) | ES2367640T3 (pt) |
WO (1) | WO1997033602A1 (pt) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9340577B2 (en) | 1992-08-07 | 2016-05-17 | Epimmune Inc. | HLA binding motifs and peptides and their uses |
US6013258A (en) * | 1997-10-09 | 2000-01-11 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
US6183746B1 (en) | 1997-10-09 | 2001-02-06 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
EP1064022A4 (en) * | 1998-03-13 | 2004-09-29 | Epimmune Inc | HLA BINDING PEPTIDES AND THEIR APPLICATIONS |
WO2000044775A2 (en) * | 1999-01-27 | 2000-08-03 | Epimmune Inc. | Identification of broadly reactive hla restricted t cell epitopes |
US7361338B2 (en) | 1999-10-05 | 2008-04-22 | Agensys, Inc. | Methods to inhibit growth of prostate cancer cells |
CA2386341A1 (en) * | 1999-11-18 | 2001-05-25 | Epimmune Inc. | Heteroclitic analogs and related methods |
US7462354B2 (en) | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
CA2415923C (en) | 2000-07-12 | 2011-10-25 | Agensys, Inc. | Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
EP2022797A3 (en) | 2000-08-28 | 2011-11-09 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer |
US7459539B2 (en) | 2000-12-15 | 2008-12-02 | Agensys, Inc. | Antibody that binds zinc transporter protein 108P5H8 |
US6924358B2 (en) | 2001-03-05 | 2005-08-02 | Agensys, Inc. | 121P1F1: a tissue specific protein highly expressed in various cancers |
US7271240B2 (en) | 2001-03-14 | 2007-09-18 | Agensys, Inc. | 125P5C8: a tissue specific protein highly expressed in various cancers |
US20030191073A1 (en) | 2001-11-07 | 2003-10-09 | Challita-Eid Pia M. | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
US7736654B2 (en) | 2001-04-10 | 2010-06-15 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
WO2002092842A2 (en) * | 2001-05-15 | 2002-11-21 | Agensys, Inc. | Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
WO2002094994A2 (en) | 2001-05-18 | 2002-11-28 | Mayo Foundation For Medical Education And Research | Chimeric antigen-specific t cell-activating polypeptides |
US20060222656A1 (en) | 2005-04-01 | 2006-10-05 | University Of Maryland, Baltimore | MAGE-A3/HPV 16 peptide vaccines for head and neck cancer |
ES2532757T3 (es) | 2001-09-06 | 2015-03-31 | Agensys, Inc. | Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer |
WO2003087126A2 (en) * | 2002-04-05 | 2003-10-23 | Epimmune Inc. | Heteroclitic analogs and related methods |
JP2005535627A (ja) * | 2002-06-25 | 2005-11-24 | シティ・オブ・ホープ | アジュバント不含ペプチド・ワクチン |
AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
JP2006508163A (ja) | 2002-11-27 | 2006-03-09 | アジェンシス, インコーポレイテッド | 癌の処置および検出において有用な24p4c12と称される、核酸および対応タンパク質 |
AU2004210975B2 (en) | 2003-02-10 | 2008-04-10 | Agensys, Inc. | Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
NZ572940A (en) | 2003-05-30 | 2010-04-30 | Agensys Inc | Prostate stem cell antigen (PSCA) variants and subsequences thereof |
WO2005118864A2 (en) | 2004-05-28 | 2005-12-15 | Agensys, Inc. | Antibodies and related molecules that bind to psca proteins |
RU2413735C2 (ru) | 2005-03-31 | 2011-03-10 | Эдженсис, Инк. | Антитела и родственные молекулы, связывающиеся с белками 161p2f10b |
EP1982728A4 (en) * | 2006-01-23 | 2009-11-11 | Greenpeptide Co Ltd | HEPATITIS C-VIRUS DERIVED PEPTIDE |
US20090023895A1 (en) * | 2006-02-07 | 2009-01-22 | Nec Corporation | Hla-binding peptide, precursor thereof, and dna fragment and recombinant vector coding for said hla-binding peptide |
US8324345B2 (en) | 2006-10-12 | 2012-12-04 | Nec Corporation | HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same |
CN102066410B (zh) | 2007-11-01 | 2017-01-18 | 梅约医学教育与研究基金会 | Hla‑dr结合肽和它们的应用 |
WO2010086294A2 (en) | 2009-01-28 | 2010-08-05 | Epimmune Inc. | Pan-dr binding polypeptides and uses thereof |
SG10201604236RA (en) * | 2011-05-26 | 2016-07-28 | Geneius Biotechnology Investments Llc | Modulated Immunodominance Therapy |
CN110651189A (zh) | 2017-03-03 | 2020-01-03 | 特雷斯生物公司 | 肽疫苗 |
MA53543A (fr) | 2018-09-04 | 2021-07-14 | Treos Bio Ltd | Vaccins peptidiques |
US11161892B1 (en) | 2020-12-07 | 2021-11-02 | Think Therapeutics, Inc. | Method of compact peptide vaccines using residue optimization |
US11421015B2 (en) | 2020-12-07 | 2022-08-23 | Think Therapeutics, Inc. | Method of compact peptide vaccines using residue optimization |
US11058751B1 (en) | 2020-11-20 | 2021-07-13 | Think Therapeutics, Inc. | Compositions for optimized RAS peptide vaccines |
US11464842B1 (en) | 2021-04-28 | 2022-10-11 | Think Therapeutics, Inc. | Compositions and method for optimized peptide vaccines using residue optimization |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200320A (en) * | 1987-12-07 | 1993-04-06 | National Jewish Center For Immunology And Respiratory Medicine | Method for identifying useful polypeptide vaccines |
CA2141960A1 (en) | 1992-08-07 | 1994-02-17 | Ralph T. Kubo | Hla binding peptides and their uses |
US20050271676A1 (en) * | 1993-03-05 | 2005-12-08 | Epimmune Inc. | Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
CA2168583C (en) * | 1993-08-02 | 2007-10-02 | Francis V. Chisari | Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
KR100235849B1 (ko) * | 1993-10-19 | 1999-12-15 | 에가시라 구니오 | HIV에 대한 면역응답을 유도할 수 있는 펩티드 및 그 펩티드를 함유하는 항 AIDS 예방, 치료제(Peptides Capable of Inducing Immune Response to HIV and Anti-AIDS Agent for Preventing and Curing AIDS) |
-
1997
- 1997-03-10 BR BR9708161A patent/BR9708161A/pt not_active IP Right Cessation
- 1997-03-10 AT AT97914975T patent/ATE511849T1/de not_active IP Right Cessation
- 1997-03-10 AU AU22037/97A patent/AU2203797A/en not_active Abandoned
- 1997-03-10 JP JP53275997A patent/JP2001504799A/ja not_active Withdrawn
- 1997-03-10 ES ES97914975T patent/ES2367640T3/es not_active Expired - Lifetime
- 1997-03-10 WO PCT/US1997/003778 patent/WO1997033602A1/en active Application Filing
- 1997-03-10 CA CA002248657A patent/CA2248657A1/en not_active Abandoned
- 1997-03-10 CN CN97194430A patent/CN1225590A/zh active Pending
- 1997-03-10 EP EP97914975A patent/EP0914142B9/en not_active Expired - Lifetime
-
2008
- 2008-12-24 JP JP2008327605A patent/JP2009108097A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2009108097A (ja) | 2009-05-21 |
WO1997033602A1 (en) | 1997-09-18 |
EP0914142B9 (en) | 2012-01-04 |
CA2248657A1 (en) | 1997-09-18 |
ATE511849T1 (de) | 2011-06-15 |
CN1225590A (zh) | 1999-08-11 |
EP0914142B1 (en) | 2011-06-08 |
AU2203797A (en) | 1997-10-01 |
ES2367640T3 (es) | 2011-11-07 |
EP0914142A4 (en) | 2004-06-23 |
JP2001504799A (ja) | 2001-04-10 |
EP0914142A1 (en) | 1999-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9708161A (pt) | Peptídeos com aumentada afinidade de ligação para moléculas hla | |
DE69711083D1 (de) | Kontaktstift für prüfzwecke | |
DE69729829D1 (de) | Zusammensetzung für Wasser-enthaltende Dispersion | |
WO1999015658A3 (en) | Human regulatory molecules | |
DE69818157D1 (de) | Instrument für Eingriffe am Uterus | |
DE69017300D1 (de) | Nager mit geringem Verschleiss für chirurgischen Retraktor. | |
EA199800667A1 (ru) | Новые фенантридины | |
ATE424560T1 (de) | Marker für neuromyelitis optica | |
ATE346922T1 (de) | Domäne 1 beta2-gpi polypetiden und deren diagnostische und therepeutische verwendungen | |
DE69005530D1 (de) | Lüfteranordnung für Wechselstromfahrzeuggenerator. | |
DE69830255D1 (de) | Testeinheit zur Prüfung von Steckverbindern | |
BR9804676A (pt) | Processo para o teste de um dispositivo de embreagem automatizado. | |
DE19780486T1 (de) | Druck-Zug-Ventilanordnung für einen Motorzylinder | |
DE69715430D1 (de) | Hydrodynamische schmiermitteldichtung für niedrige drehmomente | |
DE69721506D1 (de) | Betriebsverfahren für eine ionenfalle | |
DE69625833D1 (de) | Testkarte für Analysen | |
ATE404208T1 (de) | Uridin-therapie für patienten mit erhöhten purin- werten | |
DE59005619D1 (de) | Rollenprüfstand zur kombinierten Leistungs- und Bremsenprüfung an Kraftfahrzeugen. | |
DK0929299T3 (da) | Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner | |
BR9808729A (pt) | Processo para a preparação de um anti-oxidante | |
PT801179E (pt) | Dispositivo para controlo da valvula de um autoclismo | |
DE59610901D1 (de) | Gehäuse für eine elektrische Baugruppe | |
NO900052L (no) | Fremgangsmaate for betjening av en oljebroenn til havs. | |
AR019572A1 (es) | Procedimiento de adsorcion para la desaromatizacion de hidrocarburos. | |
FR2720515B1 (fr) | Instrument spatial d'observation laser, et véhicule spatial le comportant. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A , 6A , 7A , 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1855 DE 25/07/2006. |